Summit Therapeutics Overview
Summit Therapeutics Target Price
Analysts' 12-month price predictions for SMMT.
Share Price
$25.64
Average Target Price
$39.00
52.1% upside
52.1% upside5 analysts in the last 4 months
High: $44 | Low: $30
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2025-04-28 | H.C. Wainwright | $44 | 71.6% upside |  |
| 2025-04-25 | Wells Fargo | $30 | 17% upside | |
| 2025-04-25 | JefferiesKelly Shi | $44 | 71.6% upside | |
| 2025-03-26 | Summit Redstone PartnersYigal Nochomovitz | $35 | 36.5% upside | |
| 2025-02-28 | Summit Redstone Partners | $42 | 63.8% upside | |
| 2024-11-04 | JMP SecuritiesReni Benjamin | $32 | 24.8% upside | |
| 2024-09-27 | Summit Redstone PartnersYigal Nochomovitz | $23 |  10.3% downside | |
| 2024-09-25 | Stifel NicolausBrad Canino | $40 | 56% upside | |
| 2024-09-16 | H.C. WainwrightMitchell Kapoor | $45 | 75.5% upside | |
| 2024-06-03 | Stifel NicolausBrad Canino | $14 | 45.4% downside | |
| 2024-03-25 | Stifel NicolausBrad Canino | $8 | 68.8% downside | |